Page 18 - Study Design News Today

Scientific presentations demonstrate argenx’s leadership in FcRn blockade and commitment to innovating for patients across multiple neuromuscular diseases ...

? Clinical, Epidemiology and Health Economics and Outcomes Research Shared at Key Psychiatry Conference ? DUBLIN, Sept. 20, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced

/PRNewswire/ -- The Parkinsons Foundation will present six scientific posters highlighting research, care and education at the 2022 International Congress of...

Background: There is little evidence regarding the mechanisms of pectoralis major (PM) injury and player outcomes in Australian Football League (AFL) players. Purposes/Hypothesis: The study aims were to investigate (1) the mechanisms of PM muscle injury in elite AFL players via video analysis and (2) the player profile, method of management, and clinical outcomes of the PM injuries sustained. We hypothesized that the majority of PM tears would occur in outer-range PM positions (hyperextension of...

/PRNewswire/ -- The "Virtual Clinical Trials Market Size, Share & Trends Analysis Report by Study Design (Interventional, Observational, Expanded Access), by...

/PRNewswire/ -- The "Global HIV Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design...

Dublin, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trials Market Size, Share & Trends Analysis Report by Study Design (Interventional,...

/PRNewswire/ -- The "Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design, by...

Dublin, June 28, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III,...

Describing the current therapeutic landscape for Retinitis Pigmentosa and the disease burden for patients, caregivers, and society. Read more